Sale!

LEMD3 Gene Buschke-Ollendorff Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LEMD3 Gene Buschke-Ollendorff Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the LEMD3 gene, which are linked to the development of Buschke-Ollendorff Syndrome (BOS). BOS is a rare genetic disorder characterized by skin manifestations, such as connective tissue nevi, and osteopoikilosis, a condition where bone density is increased in certain areas, leading to a spotted appearance on X-rays. The test plays a crucial role in confirming the diagnosis of BOS, enabling healthcare providers to offer appropriate management and counseling for affected individuals and their families.

Performed at DNA Labs UAE, a leading facility in genetic testing, the LEMD3 Gene Buschke-Ollendorff Syndrome Genetic Test is conducted through advanced molecular techniques to ensure high accuracy and reliability. The test cost is set at 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. By opting for this test, patients and their families can gain valuable insights into their genetic health, paving the way for informed medical and personal decisions.

Description

LEMD3 Gene Buschke-Ollendorff Syndrome Genetic Test

Test Name: LEMD3 Gene Buschke-Ollendorff Syndrome Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for LEMD3 Gene Buschke-Ollendorff Syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LEMD3 Gene Buschke-Ollendorff Syndrome NGS Genetic DNA Test gene LEMD3.

Test Details: The LEMD3 gene is associated with Buschke-Ollendorff Syndrome, a rare genetic disorder characterized by the development of multiple connective tissue tumors called osteopoikilosis and skin manifestations such as dermal nevi and collagenomas. NGS (Next-Generation Sequencing) genetic testing refers to a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of Buschke-Ollendorff Syndrome, NGS genetic testing can be used to identify mutations or variants in the LEMD3 gene, which can help confirm a diagnosis of the condition. NGS testing involves extracting DNA from a patient’s blood or tissue sample, followed by library preparation, sequencing, and data analysis. This comprehensive approach enables the detection of various types of genetic alterations, including single nucleotide variants, insertions, deletions, and structural rearrangements in the LEMD3 gene. By identifying specific mutations or variants in the LEMD3 gene, NGS genetic testing can aid in the diagnosis of Buschke-Ollendorff Syndrome, inform genetic counseling, and facilitate the management and treatment of affected individuals and their families.

Test Name	LEMD3 Gene Buschke-Ollendorff syndrome Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for LEMD3 Gene Buschke-Ollendorff syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LEMD3 Gene Buschke-Ollendorff syndrome NGS Genetic DNA Test gene LEMD3
Test Details	The LEMD3 gene is associated with Buschke-Ollendorff syndrome, a rare genetic disorder characterized by the development of multiple connective tissue tumors called osteopoikilosis and skin manifestations such as dermal nevi and collagenomas. NGS (Next-Generation Sequencing) genetic testing refers to a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of Buschke-Ollendorff syndrome, NGS genetic testing can be used to identify mutations or variants in the LEMD3 gene, which can help confirm a diagnosis of the condition. NGS testing involves extracting DNA from a patient’s blood or tissue sample, followed by library preparation, sequencing, and data analysis. This comprehensive approach enables the detection of various types of genetic alterations, including single nucleotide variants, insertions, deletions, and structural rearrangements in the LEMD3 gene. By identifying specific mutations or variants in the LEMD3 gene, NGS genetic testing can aid in the diagnosis of Buschke-Ollendorff syndrome, inform genetic counseling, and facilitate the management and treatment of affected individuals and their families.